Xu Zishu, Qi Lu, Su Shiqiong, Xu Zhijing, Geng Yuan, Shi Yangang, Wang Congmei, Wu Jie, Liu Ruifang
Department of Intensive Care Medicine, The Third People's Hospital of Henan Province, Zhengzhou, China.
PLoS One. 2025 Jun 3;20(6):e0325316. doi: 10.1371/journal.pone.0325316. eCollection 2025.
The aim of this study was to evaluate and compare the predictive value of the neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) for nosocomial infection in patients undergoing veno-arterial extracorporeal membrane oxygenation (VA-ECMO).
In this retrospective cohort study, we assessed 95 patients who underwent VA-ECMO between 2018 and 2023 at the Third People's Hospital of Henan Province. The association between NLR, PLR and nosocomial infection in patients undergoing VA-ECMO was tested using logistic regression model.
Among 95 VA-ECMO patients, 30 were found to have developed nosocomial infection (infection rate 31.58%). Patients with higher levels of NLR and PLR showed higher rates of nosocomial infections (p < 0.05). Higher NLR were associated with an increased risk of nosocomial infections in patients undergoing VA-ECMO (odds ratio [OR], 4.858; 95% confidence interval [95% CI], 1.864-12.663) (P = 0.001), after adjusting for sex, age, hemoglobin, albumin, and duration of VA-ECMO treatment. In reference to the first tertile of NLR, ORs were 6.931 (95% CI, 1.496-32.118) for the second tertile, 8.898 (95% CI, 1.943-40.751) for the third tertile. PLR was a risk factor for nosocomial infections in patients undergoing VA-ECMO (OR 5.478; 95%CI 2.117-14.176) after adjusting for traditional risk factors (P < 0.001). ROC curve analysis showed that the area under the curve (AUC) of NLR and PLR to predict nosocomial infections in patients treated with VA-ECMO were 0.710 and 0.763, respectively.
High NLR and PLR were associated with an increased risk of nosocomial infection in patients treated with VA-ECMO.
本研究旨在评估和比较中性粒细胞与淋巴细胞比值(NLR)和血小板与淋巴细胞比值(PLR)对接受静脉-动脉体外膜肺氧合(VA-ECMO)治疗的患者发生医院感染的预测价值。
在这项回顾性队列研究中,我们评估了2018年至2023年期间在河南省第三人民医院接受VA-ECMO治疗的95例患者。使用逻辑回归模型检验接受VA-ECMO治疗的患者中NLR、PLR与医院感染之间的关联。
在95例接受VA-ECMO治疗的患者中,有30例发生了医院感染(感染率31.58%)。NLR和PLR水平较高的患者医院感染率较高(p<0.05)。在调整了性别、年龄、血红蛋白、白蛋白和VA-ECMO治疗持续时间后,较高的NLR与接受VA-ECMO治疗的患者发生医院感染的风险增加相关(比值比[OR],4.858;95%置信区间[95%CI],1.864-12.663)(P=0.001)。参照NLR的第一个三分位数,第二个三分位数的OR为6.931(95%CI,1.496-32.118),第三个三分位数的OR为8.898(95%CI,1.943-40.751)。在调整传统危险因素后,PLR是接受VA-ECMO治疗的患者发生医院感染的危险因素(OR 5.478;95%CI 2.117-14.176)(P<0.001)。ROC曲线分析表明,NLR和PLR预测接受VA-ECMO治疗患者发生医院感染的曲线下面积(AUC)分别为0.710和0.763。
高NLR和PLR与接受VA-ECMO治疗的患者发生医院感染的风险增加相关。